MX2017005776A - Suplementos nutricionales que contienen componente peptidico y usos de los mismos. - Google Patents

Suplementos nutricionales que contienen componente peptidico y usos de los mismos.

Info

Publication number
MX2017005776A
MX2017005776A MX2017005776A MX2017005776A MX2017005776A MX 2017005776 A MX2017005776 A MX 2017005776A MX 2017005776 A MX2017005776 A MX 2017005776A MX 2017005776 A MX2017005776 A MX 2017005776A MX 2017005776 A MX2017005776 A MX 2017005776A
Authority
MX
Mexico
Prior art keywords
peptide component
nutritional supplement
nutritional supplements
supplements containing
target subject
Prior art date
Application number
MX2017005776A
Other languages
English (en)
Inventor
A F Van Tol Eric
Gross Gabriele
H Schoemaker Marieke
Tim Lambers Teartse
Wielinga Peter
Kleemann Robert
Original Assignee
Mjn Us Holdings Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mjn Us Holdings Llc filed Critical Mjn Us Holdings Llc
Publication of MX2017005776A publication Critical patent/MX2017005776A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/175—Rhamnosus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Child & Adolescent Psychology (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)

Abstract

La presente descripción se refiere al suplemento nutricional que incluye un componente peptídico. El suplemento nutricional incluye además una fuente de ácidos grasos poliinsaturados de cadena larga y Lactobacillus rhamnosus GG. La descripción se refiere además a los métodos de protección contra la obesidad y sus trastornos metabólicos relacionados, y las enfermedades inflamatorias en un sujeto objetivo, al proporcionar el o los suplementos nutricionales descritos en la presente a un sujeto objetivo, el cual incluye un sujeto pediátrico.
MX2017005776A 2014-11-06 2015-10-07 Suplementos nutricionales que contienen componente peptidico y usos de los mismos. MX2017005776A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14/535,241 US10251928B2 (en) 2014-11-06 2014-11-06 Nutritional supplements containing a peptide component and uses thereof
PCT/US2015/054383 WO2016073126A1 (en) 2014-11-06 2015-10-07 Nutritional supplements containing a peptide component and uses thereof

Publications (1)

Publication Number Publication Date
MX2017005776A true MX2017005776A (es) 2017-07-28

Family

ID=54337903

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017005776A MX2017005776A (es) 2014-11-06 2015-10-07 Suplementos nutricionales que contienen componente peptidico y usos de los mismos.

Country Status (12)

Country Link
US (3) US10251928B2 (es)
EP (1) EP3214953A1 (es)
CN (1) CN107073071A (es)
AR (1) AR102545A1 (es)
AU (1) AU2015343607A1 (es)
BR (1) BR112017008776A2 (es)
CA (1) CA2962133A1 (es)
MX (1) MX2017005776A (es)
PH (1) PH12017500740A1 (es)
SG (1) SG11201702035WA (es)
TW (1) TW201628509A (es)
WO (1) WO2016073126A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180153951A1 (en) * 2016-12-05 2018-06-07 Mead Johnson Nutrition Company Methods for Inducing Adipocyte Browning, Improving Metabolic Flexibility, and Reducing Detrimental White Adipocyte Tissue Deposition and Dysfunction
JP7136807B2 (ja) 2017-04-17 2022-09-13 ザ・ユニバーシティ・オブ・シカゴ ヒトの健康及び疾患の治療用途向けの短鎖脂肪酸の腸への送達用ポリマー材料

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5407957A (en) 1990-02-13 1995-04-18 Martek Corporation Production of docosahexaenoic acid by dinoflagellates
EP1787532A3 (en) 1991-01-24 2010-03-31 Martek Biosciences Corporation Microbial oil mixtures and uses thereof
US5374567A (en) 1993-05-20 1994-12-20 The United States Of America As Represented By The Secretary Of The Navy Operational amplifier using bipolar junction transistors in silicon-on-sapphire
GB9310472D0 (en) * 1993-05-20 1993-07-07 Univ Warwick Phenylalanine-free protein and dna coding thereof
US6884294B2 (en) 2001-04-16 2005-04-26 Tokyo Electron Limited Coating film forming method and apparatus
US20040132819A1 (en) 2002-08-06 2004-07-08 Nancy Auestad Appetite control method
TW200412942A (en) 2002-08-06 2004-08-01 Abbott Lab Appetite control method
AU2003207417A1 (en) 2003-02-07 2004-08-30 Campina B.V. Use of tryptophan rich peptides
WO2005063050A1 (en) 2003-12-19 2005-07-14 Abbott Laboratories Method of increasing lean body mass and reducing body fat mass in infants
CA2558155A1 (en) * 2004-03-01 2005-09-09 Zvi Sidelman Casein derived peptides and therapeutic uses thereof
US20060286208A1 (en) * 2005-06-01 2006-12-21 Nagendra Rangavajla Methods for producing protein partial hydrolysates and infant formulas containing the same
US7618669B2 (en) 2005-06-01 2009-11-17 Mead Johnson Nutrition Company Low-lactose partially hydrolyzed infant formula
DE602006016444D1 (de) 2005-07-01 2010-10-07 Nutricia Nv Babynahrung mit hydrolisierten proteinen
WO2008054192A1 (en) 2006-11-02 2008-05-08 N.V. Nutricia Use of nutritional compositions for preventing disorders
PL1962823T3 (pl) 2005-12-23 2015-08-31 Nutricia Nv Kompozycja zawierająca wielonienasycone kwasy tłuszczowe, białka i mangan i/lub molibden do poprawy składu błony komórkowej
WO2007100562A2 (en) 2006-02-28 2007-09-07 Bristol-Myers Squibb Company Use of dha and ara in the preparation of a composition for reducing triglyceride levels
CA2645123A1 (en) 2006-02-28 2007-09-07 Bristol-Myers Squibb Company Use of dha and ara in the preparation of a composition for regulating gene expression
EP1988888A2 (en) 2006-02-28 2008-11-12 Bristol-Myers Squibb Company Use of dha and ara in the preparation of a composition for preventing or treating obesity
WO2007116091A1 (en) 2006-04-12 2007-10-18 Dsm Ip Assets B.V. Novel nutraceutical compositions
JP5735734B2 (ja) 2009-04-16 2015-06-17 雪印メグミルク株式会社 脂質代謝改善剤
EP2353595B1 (en) 2010-01-19 2015-10-28 MJN U.S. Holdings LLC Nutritional compensation for western-type diet
US9345727B2 (en) * 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component and uses thereof
US9345741B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof
US8889633B2 (en) 2013-03-15 2014-11-18 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof
US9289461B2 (en) 2013-03-15 2016-03-22 Mead Johnson Nutrition Company Reducing the risk of autoimmune disease

Also Published As

Publication number Publication date
US20210244787A9 (en) 2021-08-12
BR112017008776A2 (pt) 2018-05-15
CN107073071A (zh) 2017-08-18
US10251928B2 (en) 2019-04-09
AR102545A1 (es) 2017-03-08
PH12017500740A1 (en) 2017-10-09
AU2015343607A1 (en) 2017-03-30
US11077166B2 (en) 2021-08-03
US20160129071A1 (en) 2016-05-12
SG11201702035WA (en) 2017-04-27
US20190224273A1 (en) 2019-07-25
CA2962133A1 (en) 2016-05-12
WO2016073126A1 (en) 2016-05-12
TW201628509A (zh) 2016-08-16
US20190240283A1 (en) 2019-08-08
EP3214953A1 (en) 2017-09-13
US10933114B2 (en) 2021-03-02

Similar Documents

Publication Publication Date Title
MY188027A (en) Fat composition and fat blend
EP4299122A3 (en) Compositions and methods for treating skin and mucous membrane diseases
PL3319620T3 (pl) Bakteria lactobacillus paracasei do produkcji sprzężonego kwasu linolowego, zawierające ją preparaty odżywcze i farmaceutyczne oraz ich zastosowania
EP3661600A4 (en) FATTY ACID ANALOGS AND ITS USE IN THE TREATMENT OF DISEASES RELATED TO METABOLISM SYNDROME
MY190647A (en) Compounds effective in treating hepatotoxicity and fatty liver diseases and uses thereof
PH12017500498A1 (en) Nutritional composition for gastrointestinal environment to provide improved microbiome and metabolic profile
EP2994165A4 (en) Nutritional or dietary supplements containing fatty acids and nitrite
EP3197857A4 (en) Fatty acid composition and method for fortifying nutritional products with fatty acids
PH12018500993A1 (en) Nutritional compositions comprising lactobacillus rhamnosus gg, as well as dietary butyrate and/or a compound for stimulating formation of endogenous butyrate
PH12019501295A1 (en) Nutritional compositions containing butyrate and/or lactoferrin and uses thereof
PT3180424T (pt) 3alfa-hidroxisteroide desidrogenase mutantes e processo para a produção de ácido ursodesoxicólico
WO2016040570A3 (en) Dietary emulsion formulations and methods for using the same
ZA202003101B (en) A dietary composition comprising plant-based sources of fatty acids
EP3625339A4 (en) MODIFICATIONS TO LYSIN DECARBOXYLASE ENZYMES
PL3342869T3 (pl) Mikroorganizm z rodzaju Corynebacterium do wytwarzania L-aminokwasu i sposób wytwarzania L-aminokwasu przy jego zastosowaniu
PH12017500740A1 (en) Nutritional supplements containing a peptide component and uses thereof
EP3261622A4 (en) Millicapsule formulations comprising polyunsaturated free fatty acids
EP3220933A4 (en) Method of increasing levels of omega-3 fatty acids in beef products by administration of a grass and algae diet
PH12017500738A1 (en) Feeding algae to cattle at low doses to produce high omega 3 levels in beef
WO2017055932A3 (en) Improved propionibacterium strains for the production of propionic acid
EP3027180A4 (en) Compositions and methods of the treatment of fatty acid metabolism disorders
EP3127891A4 (en) Extracts of agricultural husks used to modify the metabolism of plants
EP3370714A4 (en) COMPOSITIONS AND METHODS FOR TREATING FATTY ACID METABOLISM DISORDERS
PH12018502207A1 (en) Methods of manufacturing nutritional formulations
MX2015014450A (es) Cepa de lactobacillus rhamnosus para regular el metabolismo de lipidos.